You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oxaliplatin

Showing 1 - 25 of 2,840
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)

Not yet recruiting
  • Immunotherapy Gastrict Cancer
  • (no location specified)
Jan 17, 2023

Gastrointestinal Tumors Trial (Anti-allergic treatment)

Not yet recruiting
  • Gastrointestinal Tumors
  • Anti-allergic treatment
  • (no location specified)
Jun 19, 2023

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,

Not yet recruiting
  • Colorectal Cancer
  • HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
  • HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
  • (no location specified)
Jul 13, 2023

Advanced Gastric Carcinoma Trial in Dhaka (Trastuzumab, Oxaliplatin, Capecitabine)

Completed
  • Advanced Gastric Carcinoma
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Aug 15, 2023

Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)

Not yet recruiting
  • Neuropathy;Peripheral
  • Placebo tablets
  • Ketotifen Oral Tablet
  • Tanta, Egypt
    Tanta university
Nov 23, 2022

Chemo Induced Peripheral Neuropathy Trial (Omeprazole)

Not yet recruiting
  • Chemotherapy Induced Peripheral Neuropathy
  • (no location specified)
Jan 10, 2023

Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)

Recruiting
  • Gastric Cancer, Adjuvant Chemotherapy, XO
  • Docetaxel and capecitabine and oxaliplatin
  • capecitabine and oxaliplatin
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients Trial in Dhaka (lidocaine transdermal patch)

Recruiting
  • Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
  • lidocaine transdermal patch
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 22, 2023

Cancer Trial (Memantine, Placebo)

Not yet recruiting
  • Cancer
  • (no location specified)
Apr 17, 2023

Advanced Colorectal Cancer Trial in Guangzhou

Recruiting
  • Advanced Colorectal Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 7, 2023

    Stomach Cancer Trial in Seoul (S-1 (452500ACH), OXALIPLATIN (205803BIJ))

    Terminated
    • Stomach Cancer
    • S-1 (452500ACH)
    • OXALIPLATIN (205803BIJ)
    • Seoul, Korea, Republic of
      Kangbuk Samsung Hospital
    Dec 6, 2022

    First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,

    Not yet recruiting
    • First-line Treatment of Advanced Pancreatic Cancer
    • HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
    • nab-paclitaxel; gemcitabine
    • (no location specified)
    Feb 28, 2023

    Colorectal Cancer, Liver Cancer, Gastric Cancer Trial in Créteil, Grenoble, Paris (Acupuncture intervention, No acupuncture)

    Not yet recruiting
    • Colorectal Cancer
    • +4 more
    • Acupuncture intervention
    • No acupuncture
    • Créteil, France
    • +4 more
    May 12, 2023

    Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

    Recruiting
    • Immunotherapy
    • Gastrict Cancer
    • Fuzhou, China
      Fujian cancer hospital
    Jan 17, 2023

    Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent

    Completed
    • Gastroesophageal Junction Adenocarcinoma
    • Oxaliplatin; Capecitabine
    • Oxaliplatin; Capecitabine; concurrent radiotherapy
    • Shijiazhuang, Hebei, China
      Department of General Surgery
    Feb 4, 2022

    Colorectal Cancer, Peripheral Neuropathy Trial (Rood's approach, Traditional physical therapy program)

    Not yet recruiting
    • Colorectal Cancer
    • Peripheral Neuropathy
    • Rood's approach
    • Traditional physical therapy program
    • (no location specified)
    May 26, 2023

    Malignant Digestive System Tumor Trial in Atlanta (Fluorouracil, Leucovorin, Oxaliplatin)

    Recruiting
    • Malignant Digestive System Neoplasm
    • Atlanta, Georgia
    • +2 more
    Dec 12, 2022

    Locally Advanced Gastric Carcinoma Trial in Hanzhou (Oxaliplatin by arterial infusion plus S-1, SOX neoadjuvant, gastrectomy

    Not yet recruiting
    • Locally Advanced Gastric Carcinoma
    • Oxaliplatin by arterial infusion plus S-1
    • +3 more
    • Hanzhou, Zhejiang, China
      Gastrointestinal Department of Second Affiliated Hospital of Zhe
    Oct 20, 2022

    Peripheral Neuropathy Trial in Lebanon (Aerobic Exercise)

    Active, not recruiting
    • Peripheral Neuropathy
    • Aerobic Exercise
    • Lebanon, New Hampshire
    • +1 more
    Jun 13, 2023

    Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With

    Recruiting
    • Gastric Cancer
    • +2 more
    • Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
    • Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 18, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin

    Recruiting
    • Hepatocellular Carcinoma
    • Raltitrexed, oxaliplatin (SALOX) treatment
    • Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    May 17, 2022

    Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

    Not yet recruiting
    • Gastric Cancer Stage IV
    • Oxaliplatin
    • +5 more
    • (no location specified)
    Nov 13, 2022

    Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)

    Not yet recruiting
    • Advanced Colorectal Cancer
    • Bevacizumab combined with Oxaliplatin and TAS-102
    • (no location specified)
    May 16, 2022

    Gastric Adenocarcinoma Trial in Beijing (Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1)

    Recruiting
    • Gastric Adenocarcinoma
    • Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 27, 2022